[go: up one dir, main page]

GB202103780D0 - Formulations - Google Patents

Formulations

Info

Publication number
GB202103780D0
GB202103780D0 GBGB2103780.9A GB202103780A GB202103780D0 GB 202103780 D0 GB202103780 D0 GB 202103780D0 GB 202103780 A GB202103780 A GB 202103780A GB 202103780 D0 GB202103780 D0 GB 202103780D0
Authority
GB
United Kingdom
Prior art keywords
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2103780.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Biopharma SRL
Original Assignee
UCB Biopharma SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB Biopharma SRL filed Critical UCB Biopharma SRL
Priority to GBGB2103780.9A priority Critical patent/GB202103780D0/en
Publication of GB202103780D0 publication Critical patent/GB202103780D0/en
Ceased legal-status Critical Current

Links

GBGB2103780.9A 2021-03-18 2021-03-18 Formulations Ceased GB202103780D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2103780.9A GB202103780D0 (en) 2021-03-18 2021-03-18 Formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2103780.9A GB202103780D0 (en) 2021-03-18 2021-03-18 Formulations

Publications (1)

Publication Number Publication Date
GB202103780D0 true GB202103780D0 (en) 2021-05-05

Family

ID=75689786

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2103780.9A Ceased GB202103780D0 (en) 2021-03-18 2021-03-18 Formulations

Country Status (1)

Country Link
GB (1) GB202103780D0 (en)

Similar Documents

Publication Publication Date Title
IL287224A (en) Novel formulations comprising melflufen
GB202117828D0 (en) New formulations
IL290356A (en) Larazotide formulations
GB201915094D0 (en) New formulations
GB201904338D0 (en) Fluorouracil-containing formulations
IL284691A (en) Formulations
GB202007546D0 (en) Formulation
GB202018889D0 (en) Formulations
GB202009684D0 (en) Formulations
GB202009685D0 (en) Formulations
IL307849A (en) Sotorasib formulation
GB202102636D0 (en) Formulation
GB201910092D0 (en) New formulations
GB202115121D0 (en) Formulations
GB202115127D0 (en) Formulations
GB202103785D0 (en) Formulations
GB202103780D0 (en) Formulations
GB202103762D0 (en) Formulations
GB202018251D0 (en) Formulations
GB202018250D0 (en) Formulations
GB202108259D0 (en) Novel formulations
IL321617A (en) Bezuclastinib formulations
GB202315863D0 (en) Formulations
GB202307059D0 (en) Formulations
GB202216961D0 (en) 5-meo-mt formulations

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)